| Rubicon Research Ltd Industry: (Pharmaceuticals - Indian - Formulations) |
|---|
|
BSE Code:
544578
ISIN Demat:
INE506V01022
Book Value(₹): 81.75 NSE Symbol:
RUBICON
Div & Yield(%):
0.09
Market Cap(₹ Cr): 28,415.60 P/E(TTM):
120.71
EPS(TTM):
14.22
Face Value(₹): 1.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 16.51 | 15.41 | 15.21 | 5.07 | 5.07 |
| Reserves | 1,336.76 | 652.37 | 460.66 | 281.31 | 423.54 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 1,353.27 | 667.78 | 475.87 | 286.38 | 428.61 |
| Secured Loans | 116.35 | 328.70 | 303.81 | 317.55 | 154.78 |
| Unsecured Loans | 159.69 | 79.32 | 107.99 | 2.12 | 14.42 |
| Total Debt | 276.04 | 408.02 | 411.80 | 319.67 | 169.20 |
| Other Liabilities | 11.64 | 9.55 | 4.39 | 3.28 | 1.72 |
| Total Liabilities | 1,640.95 | 1,085.35 | 892.06 | 609.33 | 599.53 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 652.01 | 461.41 | 410.00 | 358.99 | 299.40 |
| Less: Accumulated Depreciation | 235.72 | 202.09 | 178.26 | 159.61 | 118.78 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 416.29 | 259.32 | 231.74 | 199.38 | 180.62 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 25.65 | 6.39 | 9.68 | 24.51 | 2.64 |
| Investments | 43.39 | 35.71 | 33.71 | 0.05 | 18.62 |
| Current Assets, Loans & Advances | |||||
| Inventories | 347.82 | 257.92 | 181.47 | 167.21 | 57.55 |
| Sundry Debtors | 713.43 | 501.41 | 252.05 | 224.98 | 233.63 |
| Cash and Bank Balance | 251.04 | 37.11 | 48.25 | 58.91 | 43.50 |
| Loans and Advances | 102.21 | 153.89 | 88.75 | 50.49 | 63.35 |
| Total Current Assets | 1,414.50 | 950.32 | 570.51 | 501.59 | 398.03 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 332.20 | 222.39 | 122.05 | 116.04 | 73.82 |
| Provisions | 2.36 | 33.18 | 2.50 | 22.89 | 1.07 |
| Total CL & Provisions | 334.56 | 255.58 | 124.55 | 138.93 | 74.90 |
| Net Current Assets | 1,079.94 | 694.75 | 445.96 | 362.65 | 323.13 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 5.35 | 1.77 | 0.92 | 0.00 | 0.00 |
| Deferred Tax Liability | 0.00 | 0.00 | 0.00 | 1.45 | 3.91 |
| Net Deferred Tax | 5.35 | 1.77 | 0.92 | -1.45 | -3.91 |
| Other Assets | 70.33 | 87.42 | 170.03 | 24.18 | 78.43 |
| Total Assets | 1,640.95 | 1,085.37 | 892.04 | 609.31 | 599.53 |
| Contingent Liabilities | 886.35 | 411.90 | 144.16 | 9.05 | 0.00 |